Five-year real-world data on fingolimod treatment's effects on cognitive function

Mult Scler Relat Disord. 2021 Sep:54:103089. doi: 10.1016/j.msard.2021.103089. Epub 2021 Jun 22.

Authors

S Ozakbas¹, B Piri Cinar², P Yigit¹, C Baba¹, O Sagici¹; Multiple Sclerosis Research Group

Affiliations

¹ Dokuz Eylul University, Neurology Department, Izmir, Turkey.
² Zonguldak Bulent Ecevit University, Neurology Department, Zonguldak, Turkey. Electronic address: bilge.cinarpiri@gmail.com.

PMID: 34198030
DOI: 10.1016/j.msard.2021.103089

No abstract available

Keywords: Cognition; Fingolimod; Multiple sclerosis.

MeSH terms

Cognition
Fingolimod Hydrochloride / therapeutic use
Humans
Immunosuppressive Agents / adverse effects
Multiple Sclerosis* / drug therapy
Multiple Sclerosis* / epidemiology
Multiple Sclerosis, Relapsing-Remitting*

Substances

Immunosuppressive Agents
Fingolimod Hydrochloride